BIRC5 and non-small cell lung carcinoma: It is worth noting that circulating anti‐BIRC5 IgG may have a prognostic value as NSCLC patients with high anti‐BIRC5b IgG levels survived longer than those with low anti‐BIRC5b IgG levels (Table 7 and Fig. 1).